Indication
Von Willebrand's Disease
1 clinical trial
1 product
Product
Efanesoctocog alfaClinical trial
A Phase 1, Open-Label Study to Assess the Pharmacokinetics, and Safety and Tolerability of a Single Intravenous Injection of rFVIIIFc-VWF-XTEN (BIVV001) in Adults With Type 2N and 3 Von Willebrand Disease (VWD)Status: Completed, Estimated PCD: 2022-12-01